Finally, CDK4/6 amplification or overexpression has also been observed in a wide spectrum of tumors, including gliomas, sarcomas, lymphomas, melanomas, cancers of the breast, squamous cell carcinomas and leukemias [reviewed in 118, 123]. The gene discussed is CDK4; the disease is central nervous system cancer.